"As previously announced, the Company (4DMedical) has commercial contracts for CT:VQ™ for use in clinical trials at Brooke Army Medical Center (the U.S. Department of Defense's largest facility and only Level 1 trauma center) and with several companies undertaking clinical trials of their pre-release products."
@asx11 it looks like we will see them going head-to-head sooner rather than later. The big deployment by CYC is the same place as the pilot program by 4DX for their blockbuster SPECT disrupting solution CT:VQ.
They will be testing CT:VQ against their incumbent, Technegas.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)